Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.K. to Tighten Rules for Foreign Bidders, Cable Says
Bloomberg
Sunday, July 13, 2014 - 11:12am
tags:
UK, M&A
Where Are We At With AbbVie's Acquisition Of Shire? (ABBV)
Seeking Alpha
Sunday, July 13, 2014 - 11:10am
tags:
AbbVie, Shire, M&A
Mylan near multibillion-dollar deal for Abbott drug assets - sources
Global Post
Saturday, July 12, 2014 - 12:04pm
tags:
Mylan, Abbott Laboratories
The FDA is Cracking Down on Big Pharma Social Media
Time
Saturday, July 12, 2014 - 11:35am
tags:
social media
Roche Collaborates with Merck KGaA
Yahoo/Zacks
Saturday, July 12, 2014 - 11:08am
tags:
Roche, Merck KGaA, diagnostics
Is This MannKind's Greatest Risk?
Motley Fool
Saturday, July 12, 2014 - 10:39am
tags:
MannKind, Afrezza
1 Drug More Important to Gilead Than Sovaldi
Motley Fool
Saturday, July 12, 2014 - 10:37am
tags:
Truvada, Gilead Sciences, HIV
Johnson & Johnson Earnings Preview: Pharma Buisness To Remain Strong
Seeking Alpha
Saturday, July 12, 2014 - 10:35am
tags:
JNJ, earnings
A Global Pharma Boom Is Coming... Here's How To Profit
Yahoo/Street Authority
Saturday, July 12, 2014 - 10:34am
tags:
Sanofi
England Asks Illumina to Map 100,000 Genomes
Bloomberg
Saturday, July 12, 2014 - 10:32am
tags:
Illumina, genome sequencing
France Not Retreating from Gilead Sciences (video)
Motley Fool
Saturday, July 12, 2014 - 10:29am
tags:
France, Gilead Sciences, Sovaldi, hepatitis C
Oncolytics Up on Patient Enrolment Completion
Yahoo/Zacks
Saturday, July 12, 2014 - 10:27am
tags:
Oncolytics
U.S. senators ask Gilead to explain cost of Sovaldi hepatitis drug
Yahoo/Reuters
Saturday, July 12, 2014 - 10:26am
tags:
Gilead Sciences, Sovaldi
Doc Quits FDA Panel Reviewing J&J Device Over Conflict of Interest
WSJ Online
Friday, July 11, 2014 - 4:58pm
tags:
FDA, devices, J&J, Ethicon, physicians
Osiris Therapeutics' Survival In Doubt After Losing 'Pass-Through' Status In 2015
Seeking Alpha
Friday, July 11, 2014 - 12:05pm
tags:
Osiris Therapeutics, stem cells, Grafix
Shire Said to Hold Takeover Talks With AbbVie
Bloomberg
Friday, July 11, 2014 - 12:04pm
tags:
Shire, AbbVie, M&A
Sage's $60M swing is the next big test of biotech's IPO window
Fierce Biotech
Friday, July 11, 2014 - 11:21am
tags:
IPOs, biotech, SAGE Therapeutics
EMA: 39 human-use drug OKs in first-half 2014
Pharma Times, UK
Friday, July 11, 2014 - 11:17am
tags:
Europe, drug approvals
Covidien logs $180M charge over pelvic mesh lawsuits
Mass Device
Friday, July 11, 2014 - 11:15am
tags:
Covidien, pelvic mesh, devices
Gilead Faces New Pressure From U.S. Senators & Europe Over Hep C Pricing
W
Friday, July 11, 2014 - 11:13am
tags:
Gilead, hepatitis C, Sovaldi, drug pricing, Senate

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.